"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT01605383","Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head",,"Completed","No Results Available","Avascular Necrosis of Femur Head","Biological: XCEL-MT-OSTEO-ALPHA|Procedure: Standard treatment","Safety of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head|Feasibility of XCEL-MT-OSTEO-ALPHA in osteonecrosis of the femoral head|Bone regeneration by measuring the necrotic angle using the modified Kerboul method|Dynamic changes of signal intensity|Clinical outcomes (pain) by Visual Analogue Scale (VAS)|Clinical outcomes (SF-36)|Clinical outcome (WOMAC)","Banc de Sang i Teixits|Ministerio de Sanidad, Servicios Sociales e Igualdad|Ministerio de Ciencia e Innovación, Spain|European Regional Development Fund","All","18 Years to 50 Years   (Adult)","Phase 1|Phase 2","23","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","XCEL-MT-10-01|2010-023998-18","May 5, 2015","April 11, 2018","June 27, 2019","May 24, 2012",,"January 21, 2020","Hospital Universitari Vall d'Hebron, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT01605383"
2,"NCT02230514","Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones",,"Completed","No Results Available","Atrophic Nonunion of Fracture","Drug: XCEL-MT-OSTEO-ALPHA|Other: autologous iliac crest|Procedure: Surgery","Efficacy assessment of XCEL-MT-OSTEO-ALPHA in non-union fractures by imaging procedures|Safety assessment of XCEL-MT-OSTEO-ALPHA in non-union fractures|Efficacy assessment by quality of life test","Banc de Sang i Teixits|Hospital ASEPEYO Sant Cugat","All","18 Years to 65 Years   (Adult, Older Adult)","Phase 1|Phase 2","19","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","XCEL-PSART-01|2013-005025-23","November 20, 2014","March 5, 2019","December 20, 2019","September 3, 2014",,"April 12, 2021","Hospital ASEPEYO Sant Cugat, Sant Cugat, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT02230514"
3,"NCT01552707","Safety Study of Mesenchymal Stem Cells and Spinal Fusion",,"Completed","No Results Available","Lumbar Spondylolisthesis Involving L4-L5, and/or|Degenerative Discopathy Involving L4-L5","Biological: XCEL-MT-OSTEO-ALPHA|Procedure: Standard treatment","safety of XCEL-MT-OSTEO-ALPHA (tissue engineering product composed by ""ex-vivo"" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion)|Feasibility of XCEL-MT-OSTEO-ALPHA (composed by ""ex-vivo"" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion)|Efficacy spinal fusion by imaging procedures (X-Ray).|Efficacy spinal fusion by imaging procedures (computerized helicoidal tomography)|Clinical outcomes (VAS)|Clinical outcomes (SF-36)|Clinical outcome (Oswestry Disability Index)","Banc de Sang i Teixits|TFS Trial Form Support|Ministerio de Sanidad, Servicios Sociales e Igualdad|Ministerio de Ciencia e Innovación, Spain","All","18 Years to 85 Years   (Adult, Older Adult)","Phase 1|Phase 2","69","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","XCEL-MT-10-02","July 19, 2012","May 3, 2018","October 21, 2019","March 13, 2012",,"January 21, 2020","Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Parc de Salut Mar, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Institut Universitari Dexeus (ICATME), Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain",,"https://ClinicalTrials.gov/show/NCT01552707"
